• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较有和无心脏外科手术现场的中心治疗的多血管疾病患者。

Comparison of patients with multivessel disease treated at centers with and without on-site cardiac surgery.

机构信息

Department of Cardiac Surgery, Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Department of Cardiology, Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

出版信息

J Thorac Cardiovasc Surg. 2018 Mar;155(3):865-873.e3. doi: 10.1016/j.jtcvs.2017.09.144. Epub 2017 Nov 9.

DOI:10.1016/j.jtcvs.2017.09.144
PMID:29452484
Abstract

BACKGROUND

The regional needs and consolidation of cardiac surgery services (CSS) result in an increased number of stand-alone interventional cardiology units. We aimed to explore the impact of a heart team on the decision making and outcomes of patients with multivessel coronary artery disease referred for coronary revascularization in stand-alone interventional cardiology units.

METHODS

This prospective study included 1063 consecutive patients with multivessel disease enrolled between January and April 2013 from all 22 hospitals in Israel that perform coronary angiography and percutaneous coronary intervention (PCI), with or without on-site CSS.

RESULTS

Of the 1063 patients, 487 (46%) underwent coronary artery bypass grafting (CABG) and 576 (54%) underwent PCI. A higher proportion of patients underwent PCI in hospitals without on-site CSS compared with those with on-site CSS (65% vs 46%; P < .001). Furthermore, patients referred to CABG from hospitals without on-site CSS had a significantly higher mean SYNTAX score compared with those who underwent CABG in centers with on-site CSS (29 vs 26; P = .018). Multivariate logistic regression analysis consistently showed that the absence of on-site cardiac surgery and a heart team was independently associated with a 2.5-fold increased likelihood for predicting the referral of PCI rather than CABG (odds ratio, 2.54; 95% confidence interval, 1.8-3.6).

CONCLUSIONS

Patients with multivessel coronary artery disease treated in centers without on-site cardiac surgery services receive a lower rate of appropriate guideline-based intervention with CABG. These findings suggest that a heart team approach should be mandatory even in centers with stand-alone interventional cardiology units.

摘要

背景

心脏手术服务(CSS)的区域需求和整合导致独立介入心脏病学单位的数量增加。我们旨在探讨心脏团队对多支冠状动脉疾病患者的决策和结果的影响,这些患者被转诊到独立介入心脏病学单位进行冠状动脉血运重建。

方法

这项前瞻性研究纳入了 2013 年 1 月至 4 月期间,来自以色列所有 22 家进行冠状动脉造影和经皮冠状动脉介入治疗(PCI)的医院的 1063 例连续多支血管疾病患者,这些医院或有或没有现场 CSS。

结果

在 1063 例患者中,487 例(46%)接受冠状动脉旁路移植术(CABG),576 例(54%)接受 PCI。与有现场 CSS 的医院相比,无现场 CSS 的医院接受 PCI 的患者比例更高(65%比 46%;P<.001)。此外,与在有现场 CSS 的中心接受 CABG 的患者相比,从无现场 CSS 的医院转诊接受 CABG 的患者的平均 SYNTAX 评分显著更高(29 比 26;P=.018)。多变量逻辑回归分析一致表明,无现场心脏手术和心脏团队与预测 PCI 而非 CABG 转诊的可能性增加 2.5 倍独立相关(优势比,2.54;95%置信区间,1.8-3.6)。

结论

在没有现场心脏手术服务的中心治疗的多支冠状动脉疾病患者接受基于指南的适当 CABG 干预的比例较低。这些发现表明,即使在拥有独立介入心脏病学单位的中心,心脏团队方法也应是强制性的。

相似文献

1
Comparison of patients with multivessel disease treated at centers with and without on-site cardiac surgery.比较有和无心脏外科手术现场的中心治疗的多血管疾病患者。
J Thorac Cardiovasc Surg. 2018 Mar;155(3):865-873.e3. doi: 10.1016/j.jtcvs.2017.09.144. Epub 2017 Nov 9.
2
Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).伴有非ST段抬高型心肌梗死的糖尿病合并多支冠状动脉疾病患者的血运重建趋势:来自国家心血管数据注册库急性冠状动脉治疗和干预结果网络注册库-遵循指南行动(NCDR ACTION注册库-GWTG)的见解
Circ Cardiovasc Qual Outcomes. 2016 May;9(3):197-205. doi: 10.1161/CIRCOUTCOMES.115.002084. Epub 2016 May 10.
3
Midterm outcomes of patients with multivessel disease treated at centers with and without on-site cardiac surgery services.在有和没有现场心脏手术服务的中心接受治疗的多支血管疾病患者的中期结果。
J Thorac Cardiovasc Surg. 2022 May;163(5):1852-1861.e3. doi: 10.1016/j.jtcvs.2020.04.170. Epub 2020 May 30.
4
Temporal Trends in Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: Insights From the Washington Cardiac Care Outcomes Assessment Program.经皮冠状动脉介入治疗和冠状动脉旁路移植术的时间趋势:来自华盛顿心脏护理结果评估计划的见解。
J Am Heart Assoc. 2020 Jun 2;9(11):e015317. doi: 10.1161/JAHA.119.015317. Epub 2020 May 27.
5
Referral to Cardiac Rehabilitation After Percutaneous Coronary Intervention, Coronary Artery Bypass Surgery, and Valve Surgery: Data From the Clinical Outcomes Assessment Program.经皮冠状动脉介入治疗、冠状动脉旁路移植术和心脏瓣膜置换术后的心脏康复转诊:来自临床结局评估项目的数据。
Circ Cardiovasc Qual Outcomes. 2017 Jun;10(6). doi: 10.1161/CIRCOUTCOMES.116.003364.
6
Comparison of long-term prognostic value of baseline SYNTAX and clinical SYNTAX scores in ST-segment elevation myocardial infarction patients with multivessel disease.ST段抬高型心肌梗死多支血管病变患者基线SYNTAX评分与临床SYNTAX评分的长期预后价值比较
Coron Artery Dis. 2016 Jun;27(4):311-8. doi: 10.1097/MCA.0000000000000365.
7
Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.在接受经皮或外科左主干血运重建的患者中,全球风险分类和临床 SYNTAX(经皮冠状动脉介入治疗与紫杉醇和心脏手术之间的协同作用)评分。
JACC Cardiovasc Interv. 2011 Mar;4(3):287-97. doi: 10.1016/j.jcin.2010.10.013.
8
Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.比较严重冠状动脉疾病患者完全血运重建患者中支架置入术与旁路移植术的疗效:SYNTAX、PRECOMBAT 和 BEST 临床试验的患者水平汇总分析
JACC Cardiovasc Interv. 2017 Jul 24;10(14):1415-1424. doi: 10.1016/j.jcin.2017.04.037.
9
Cardiology providers' recommendations for treatments and use of patient decision aids for multivessel coronary artery disease.心脏病学提供者对多血管冠状动脉疾病的治疗建议和患者决策辅助工具的使用。
BMC Cardiovasc Disord. 2021 Aug 27;21(1):410. doi: 10.1186/s12872-021-02223-y.
10
Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.冠状动脉旁路移植术与药物洗脱支架置入术治疗左主干或多支冠状动脉疾病:一项个体患者数据的荟萃分析。
JACC Cardiovasc Interv. 2016 Dec 26;9(24):2481-2489. doi: 10.1016/j.jcin.2016.10.008.

引用本文的文献

1
Remote Surgical Discussion of Multivessel Coronary Artery Disease Patients without Surgery on Site-Retrospective Insights.现场无手术情况下多支冠状动脉疾病患者的远程外科讨论——回顾性见解
J Clin Med. 2023 Dec 24;13(1):103. doi: 10.3390/jcm13010103.
2
The impact of on-site cardiac surgical backup on clinical outcomes of acute coronary syndrome-analysis of the ACSIS national registry.现场心脏外科后备支持对急性冠状动脉综合征临床结局的影响——ACSIS国家注册研究分析
Front Cardiovasc Med. 2023 Sep 1;10:1207473. doi: 10.3389/fcvm.2023.1207473. eCollection 2023.
3
The predictive value of creatinine clearance for mortality in patients undergoing revascularization.
肌酐清除率对接受血运重建术患者死亡率的预测价值。
J Cardiothorac Surg. 2021 May 1;16(1):120. doi: 10.1186/s13019-021-01502-1.
4
Real-world outcomes of different treatment strategies in patients with diabetes and three-vessel coronary disease: a mean follow-up 6.3 years study from China.中国一项平均随访 6.3 年的研究:糖尿病合并三支血管病变患者不同治疗策略的真实世界结局。
Cardiovasc Diabetol. 2021 Jan 11;20(1):16. doi: 10.1186/s12933-020-01193-3.
5
Heart teams in the Netherlands: From teamwork to data‑driven decision-making.荷兰的心脏团队:从团队合作到数据驱动的决策制定。
Neth Heart J. 2020 Aug;28(Suppl 1):73-77. doi: 10.1007/s12471-020-01452-8.
6
Impact of type 2 diabetes mellitus on short- and long-term mortality after coronary artery bypass surgery.2 型糖尿病对冠状动脉旁路手术后短期和长期死亡率的影响。
Cardiovasc Diabetol. 2018 Nov 29;17(1):151. doi: 10.1186/s12933-018-0796-7.